Multidrug resistance necessitates novel approaches to treating bacterial infections. Here, the authors apply their high-throughput screening and in silico prediction approaches to show that host receptor tyrosine kinases are good targets for host-directed therapies against intracellular bacteria.
- Cornelis J. Korbee
- Matthias T. Heemskerk
- Tom H. M. Ottenhoff
